Results 261 to 270 of about 16,339,920 (405)

Cell-Cycle Dependent Appearance of Murine Leukemia-Sarcoma Virus Antigens [PDF]

, 1974
Sandra Panem, Victoria Schauf
openalex   +1 more source

A genome-wide transcriptional analysis of the mitotic cell cycle.

Molecules and Cells, 1998
Raymond J. Cho, M. Campbell, E. Winzeler, L. Steinmetz, Andrew R. Conway, L. Wodicka, T. Wolfsberg, A. Gabrielian, D. Landsman, D. Lockhart, Ronald W. Davis   +10 more
semanticscholar   +1 more source

PYCR1 inhibition in bone marrow stromal cells enhances bortezomib sensitivity in multiple myeloma cells by altering their metabolism

Molecular Oncology, EarlyView.
This study investigated how PYCR1 inhibition in bone marrow stromal cells (BMSCs) indirectly affects multiple myeloma (MM) cell metabolism and viability. Culturing MM cells in conditioned medium from PYCR1‐silenced BMSCs impaired oxidative phosphorylation and increased sensitivity to bortezomib.
Inge Oudaert, Lauren van den Broecke, Osman Aksoy, Judith Lind, Sonia Vallet, Arne Van der Vreken, Gamze Ates, Ann Massie, Ken Maes, Kim De Veirman, Elke De Bruyne, Karin Vanderkerken, Klaus Podar, Eline Menu   +13 more
wiley   +1 more source

MicroRNA‑885‑5p regulates cell cycle progression in liver cancer cells. [PDF]

Int J Mol Med
Ariyachet C, Nokkeaw A, Tangkijvanich P.
europepmc   +1 more source

Systems Biology of the Eukaryotic Cell Cycle [PDF]

, 2005
de Lichtenberg, Ulrik
core   +1 more source

The Quantitative Behavior of Cutaneous Histamine and Mast Cells in the Hair Cycles of Rats**From the Research Laboratories of the Dermatologie Clinic of the University of Genoa, Medical School, Genoa, Italy.

, 1966
Giuseppe Moretti, Alfredo Rebora, Cinzia Giacometti, Vito Boido, E. Rampini, Carla Cipriani   +5 more
openalex   +1 more source

RNA synthesis in cells infected with herpes simple virus. XIII. Differences in the methylation patterns of viral RNA during the reproductive cycle [PDF]

, 1976
Michael J. Bartkoski, Bernard Roizman
openalex   +1 more source

In vitro properties of patient serum predict clinical outcome after high dose rate brachytherapy of hepatocellular carcinoma

Molecular Oncology, EarlyView.
Following high dose rate brachytherapy (HDR‐BT) for hepatocellular carcinoma (HCC), patients were classified as responders and nonresponders. Post‐therapy serum induced increased BrdU incorporation and Cyclin E expression of Huh7 and HepG2 cells in nonresponders, but decreased levels in responders.
Lukas Salvermoser, Jan Niklas Schäfer, Shraga Nahum Goldberg, Philipp Maximilian Kazmierczak, Moritz Nikolaus Gröper, Philipp Franz Linden, Elif Öcal, Tanja Burkard, Stefanie Corradini, Najib Ben Khaled, Moritz Wildgruber, Max Seidensticker, Jens Ricke, Matthias Stechele, Marianna Alunni‐Fabbroni   +14 more
wiley   +1 more source

Model-based inference of cell cycle dynamics captures alterations of the DNA replication programme. [PDF]

PLoS Comput Biol
Alsina A, Fumasoni M, Sartori P.
europepmc   +1 more source

A synthetic benzoxazine dimer derivative targets c‐Myc to inhibit colorectal cancer progression

Molecular Oncology, EarlyView.
Benzoxazine dimer derivatives bind to the bHLH‐LZ region of c‐Myc, disrupting c‐Myc/MAX complexes, which are evaluated from SAR analysis. This increases ubiquitination and reduces cellular c‐Myc. Impairing DNA repair mechanisms is shown through proteomic analysis.
Nicharat Sriratanasak, Bodee Nutho, Worawat Wattanathana, Narumon Phaonakrop, Bunnatut Panasawatwong, Katharina Erlenbach‐Wuensch, Sittiruk Roytrakul, Regine Schneider‐Stock, Pithi Chanvorachote   +8 more
wiley   +1 more source